Sepsis Research FEAT is delighted to report that November 2024 has been a busier-than-ever month for the charity as it undertakes two hugely important new strands of work.
The first is a revamped approach to involvement in PPIE (Patient and Public Involvement and Engagement) which enables those with lived experience to provide essential input and insight to new sepsis research studies. This is often crucial to ensuring that research projects gain approval at their very outset. It also means that the research that happens answers the key questions being raised by the sepsis community. You can find out more and register your interest in taking part in future PPIE exercises here.
The charity is also very pleased to announce support for a new study into the correct dosage and administration of antibiotics in the treatment of sepsis.
Defining Antibiotic Levels in Intensive care patients (DALI-2) picks up here in the UK on work previously carried out a decade ago in Australia by Professor Jason Roberts and his team. A fascinating two minute video from Professor Roberts explains more about the origins of the DALI studies here. The need for this new work is more pressing than ever in helping researchers to understand whether the correct doses of medicines are currently being used to treat infection in adults and children who are life-threateningly ill in intensive care. The importance of its findings in ensuring the best possible outcomes for patients, whilst simultaneously minimising the risk of antimicrobial resistance (AMR) in patients with infections cannot be overstated.